Home » Newsletters » BioWorld Science

BioWorld Science

July 13, 1998

View Archived Issues

Biapenem: safe and tolerable antibiotic for elderly subjects

Characterization of MAb 18B7, a candidate for human studies

Absence of cardiodepressive effects with beraprost

Fentanyl delivery via SmartMist provides effective analgesia

L-Ornithine-L-aspartate: safe treatment for cirrhosis and chronic hepatic encephalopathy

WR-238605 effectively protects against malaria infection in volunteer study

MacroChem and American Home Products sign collaborative agreement

Cephalon and Medtronic renew ITB copromotion agreement

Regressin holds promise for a wide range of cancers, new data indicates

Theragyn phase III testing will begin in U.K.

Phase I/II trial data released for P&U protease inhibitor

Impaired glucose tolerance and diabetes mellitus in AIDS patients treated with protease inhibitors

COL-1492 can be used several times daily without safety concerns

PRO-2000 prevents infection by STD pathogens other than HIV

Preclinical and clinical profile of (+)-calanolide A, a novel NNRTI from a natural source

Genome Therapeutics establishes licensing agreement with Princeton University

Addition of Remune to HAART leads to enhanced viral suppression

WF10, a unique AIDS treatment alternative evaluated in the clinic

Collagenase inhibitors in the pipeline at British Biotech

Merck's new tachykinin receptor antagonists useful for pain, inflammation, etc.

Subtype-selective MMP inhibitors patented by Agouron, Syntex

Antagonists of neurotrophin activity described by Allelix for pain, epilepsy and AD

New thrombin inhibitors synthesized at Merck & Co.

M-16049 compared to troglitazone for ability to improve insulin resistance

Effects of KRP-297 on progression of diabetes in db/db mice

Effects of new SGLT inhibitor on insulin and glucose in Zucker diabetic fatty rats

Aldose reductase inhibitor from Nippon Zoki effective in rats with diabetic neuropathy

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 6, 2025.
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...
Serotonin receptor modulators for the treatment of OUD
BioWorld Science
Opioid use disorder (OUD) causes high morbidity and mortality rates, with fentanyl driving unprecedented overdose rates. Researchers from the University of...
KLF15 shows potential as marker, target for cholangiocarcinoma
BioWorld Science
Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...